Renal artery stent revascularization with embolic protection in patients with ischemic nephropathy
Andrew Holden(Auckland City Hospital), Helen Pilmore, Andrew Hill(University of Auckland), Michael R. Jaff(Boston Scientific (United States))
Cited by 128
Related Papers
Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study
|The Lancet Oncology|2017|2.8k
Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer
|Journal of Clinical Oncology|2018|2.1k
American Society of Hematology 2020 Guidelines for Management of Venous Thromboembolism: Treatment of Deep Vein Thrombosis and Pulmonary Embolism
|Blood Advances|2020|1.4k
Pharmacomechanical Catheter-Directed Thrombolysis for Deep-Vein Thrombosis
|New England Journal of Medicine|2017|851
Chronic Kidney Disease and Coronary Artery Disease
|Journal of the American College of Cardiology|2019|716